SciDev Limited Logo

SciDev Limited

SDV.AX

(1.5)
Stock Price

0,58 AUD

4.25% ROA

4.43% ROE

51.94x PER

Market Cap.

112.933.380,00 AUD

6.94% DER

0% Yield

1.99% NPM

SciDev Limited Stock Analysis

SciDev Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

SciDev Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.87x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (6%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Assets Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

4 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (11) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

5 ROE

Negative ROE (-1.53%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (-1.36%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

9 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

SciDev Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

SciDev Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

SciDev Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

SciDev Limited Revenue
Year Revenue Growth
2001 0
2002 103.000 100%
2003 138.000 25.36%
2004 49.000 -181.63%
2005 69.000 28.99%
2006 3.114.000 97.78%
2007 9.564.000 67.44%
2008 27.202.000 64.84%
2009 925.000 -2840.76%
2010 549.000 -68.49%
2011 1.775.000 69.07%
2012 2.714.000 34.6%
2013 1.065.853 -154.63%
2014 1.281.439 16.82%
2015 1.536.962 16.63%
2016 1.423.072 -8%
2017 1.925.233 26.08%
2018 2.200.768 12.52%
2019 2.921.060 24.66%
2020 17.906.551 83.69%
2020 17.906.551 0%
2021 42.524.908 57.89%
2022 55.597.000 23.51%
2023 89.718.000 38.03%
2024 235.612.000 61.92%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

SciDev Limited Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 589.000 100%
2004 428.000 -37.62%
2005 377.000 -13.53%
2006 312.000 -20.83%
2007 300.000 -4%
2008 436.000 31.19%
2009 659.000 33.84%
2010 195.000 -237.95%
2011 183.000 -6.56%
2012 407.000 55.04%
2013 82.063 -395.96%
2014 52.363 -56.72%
2015 100.592 47.95%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

SciDev Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 0
2002 1.508.000 100%
2003 2.385.000 36.77%
2004 2.923.000 18.41%
2005 3.407.000 14.21%
2006 5.870.000 41.96%
2007 4.903.000 -19.72%
2008 6.188.000 20.77%
2009 4.040.000 -53.17%
2010 3.367.000 -19.99%
2011 3.600.000 6.47%
2012 3.387.000 -6.29%
2013 1.797.413 -88.44%
2014 437.929 -310.43%
2015 435.765 -0.5%
2016 106.167 -310.45%
2017 153.016 30.62%
2018 557.902 72.57%
2019 757.080 26.31%
2020 3.032.616 75.04%
2020 618.765 -390.11%
2021 382.000 -61.98%
2022 579.000 34.02%
2023 953.000 39.24%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

SciDev Limited EBITDA
Year EBITDA Growth
2001 0
2002 -1.941.000 100%
2003 -3.285.000 40.91%
2004 -4.276.000 23.18%
2005 -5.377.000 20.48%
2006 -7.469.000 28.01%
2007 -907.000 -723.48%
2008 -1.799.000 49.58%
2009 -11.065.000 83.74%
2010 -3.463.000 -219.52%
2011 2.315.000 249.59%
2012 -1.647.000 240.56%
2013 -915.890 -79.83%
2014 -779.625 -17.48%
2015 -812.733 4.07%
2016 -406.814 -99.78%
2017 -256.338 -58.7%
2018 -793.296 67.69%
2019 -1.676.971 52.69%
2020 -1.876.026 10.61%
2020 -2.512.620 25.34%
2021 416.300 703.56%
2022 1.603.000 74.03%
2023 3.964.000 59.56%
2024 22.260.000 82.19%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

SciDev Limited Gross Profit
Year Gross Profit Growth
2001 0
2002 103.000 100%
2003 138.000 25.36%
2004 49.000 -181.63%
2005 69.000 28.99%
2006 307.000 77.52%
2007 1.269.000 75.81%
2008 11.285.000 88.75%
2009 925.000 -1120%
2010 549.000 -68.49%
2011 1.775.000 69.07%
2012 2.714.000 34.6%
2013 -247.311 1197.4%
2014 671.869 136.81%
2015 767.339 12.44%
2016 664.641 -15.45%
2017 923.492 28.03%
2018 945.141 2.29%
2019 915.300 -3.26%
2020 3.140.873 70.86%
2020 -476.308 759.42%
2021 1.366.559 134.85%
2022 3.687.000 62.94%
2023 6.827.000 45.99%
2024 27.160.000 74.86%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

SciDev Limited Net Profit
Year Net Profit Growth
2001 0
2002 -3.097.000 100%
2003 -3.202.000 3.28%
2004 -2.034.000 -57.42%
2005 -3.561.000 42.88%
2006 -4.510.000 21.04%
2007 -1.172.000 -284.81%
2008 -2.826.000 58.53%
2009 -20.390.000 86.14%
2010 -1.645.000 -1139.51%
2011 1.524.000 207.94%
2012 -3.098.000 149.19%
2013 -2.567.869 -20.64%
2014 -1.177.819 -118.02%
2015 -864.312 -36.27%
2016 -480.588 -79.84%
2017 -682.151 29.55%
2018 1.001.868 168.09%
2019 -2.032.527 149.29%
2020 -875.238 -132.23%
2020 -875.238 0%
2021 3.452.968 125.35%
2022 -616.000 660.55%
2023 -339.000 -81.71%
2024 8.472.000 104%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

SciDev Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2002 -2 100%
2003 -2 -100%
2004 -1 0%
2005 -1 0%
2006 -1 0%
2007 0 0%
2008 0 0%
2009 -3 100%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

SciDev Limited Free Cashflow
Year Free Cashflow Growth
2002 -63.000
2003 -74.000 14.86%
2004 -1.989.000 96.28%
2005 -3.813.000 47.84%
2006 -1.675.000 -127.64%
2007 -4.730.000 64.59%
2008 -6.016.000 21.38%
2009 -1.057.000 -469.16%
2010 -3.725.000 71.62%
2011 -136.000 -2638.97%
2012 -239.000 43.1%
2013 -828.709 71.16%
2014 -717.934 -15.43%
2015 -1.196.428 39.99%
2016 -599.811 -99.47%
2017 -416.062 -44.16%
2018 -989.390 57.95%
2019 -1.773.273 44.21%
2020 -1.048.508 -69.12%
2021 -1.917.916 45.33%
2022 -3.829.000 49.91%
2023 522.000 833.52%
2024 5.129.000 89.82%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

SciDev Limited Operating Cashflow
Year Operating Cashflow Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 -828.709 100%
2014 -634.610 -30.59%
2015 -1.081.085 41.3%
2016 -541.397 -99.68%
2017 -225.298 -140.3%
2018 -892.345 74.75%
2019 -1.548.048 42.36%
2020 -177.465 -772.31%
2021 -1.316.872 86.52%
2022 -1.306.000 -0.83%
2023 4.814.000 127.13%
2024 6.020.000 20.03%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

SciDev Limited Capital Expenditure
Year Capital Expenditure Growth
2002 63.000
2003 74.000 14.86%
2004 1.989.000 96.28%
2005 3.813.000 47.84%
2006 1.675.000 -127.64%
2007 4.730.000 64.59%
2008 6.016.000 21.38%
2009 1.057.000 -469.16%
2010 3.725.000 71.62%
2011 136.000 -2638.97%
2012 239.000 43.1%
2013 0 0%
2014 83.324 100%
2015 115.343 27.76%
2016 58.414 -97.46%
2017 190.764 69.38%
2018 97.045 -96.57%
2019 225.225 56.91%
2020 871.043 74.14%
2021 601.044 -44.92%
2022 2.523.000 76.18%
2023 4.292.000 41.22%
2024 891.000 -381.71%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

SciDev Limited Equity
Year Equity Growth
2001 4.560.569
2002 3.611.563 -26.28%
2003 409.130 -782.74%
2004 2.467.981 83.42%
2005 10.305.334 76.05%
2006 31.504.621 67.29%
2007 34.230.000 7.96%
2008 37.050.000 7.61%
2009 5.030.000 -636.58%
2010 5.475.000 8.13%
2011 8.437.000 35.11%
2012 6.671.000 -26.47%
2013 4.042.968 -65%
2014 3.051.918 -32.47%
2015 2.243.129 -36.06%
2016 1.766.899 -26.95%
2017 2.461.700 28.22%
2018 3.950.386 37.68%
2019 4.699.021 15.93%
2020 17.409.171 73.01%
2021 31.614.557 44.93%
2022 48.837.000 35.27%
2023 48.025.000 -1.69%
2024 50.237.000 4.4%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

SciDev Limited Assets
Year Assets Growth
2001 5.077.741
2002 3.867.350 -31.3%
2003 883.237 -337.86%
2004 3.149.563 71.96%
2005 11.878.954 73.49%
2006 34.162.875 65.23%
2007 50.615.000 32.5%
2008 49.023.000 -3.25%
2009 11.166.000 -339.04%
2010 12.210.000 8.55%
2011 13.396.000 8.85%
2012 7.200.000 -86.06%
2013 4.286.547 -67.97%
2014 3.787.531 -13.18%
2015 3.076.130 -23.13%
2016 2.485.197 -23.78%
2017 3.080.228 19.32%
2018 4.563.958 32.51%
2019 5.901.965 22.67%
2020 27.172.916 78.28%
2021 56.150.588 51.61%
2022 71.157.000 21.09%
2023 67.374.000 -5.61%
2024 72.014.000 6.44%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

SciDev Limited Liabilities
Year Liabilities Growth
2001 517.172
2002 255.787 -102.19%
2003 474.107 46.05%
2004 681.582 30.44%
2005 1.573.620 56.69%
2006 2.658.254 40.8%
2007 16.385.000 83.78%
2008 11.973.000 -36.85%
2009 6.136.000 -95.13%
2010 6.735.000 8.89%
2011 4.959.000 -35.81%
2012 529.000 -837.43%
2013 243.579 -117.18%
2014 735.613 66.89%
2015 833.001 11.69%
2016 718.298 -15.97%
2017 618.528 -16.13%
2018 613.572 -0.81%
2019 1.202.944 48.99%
2020 9.763.745 87.68%
2021 24.536.031 60.21%
2022 22.320.000 -9.93%
2023 19.349.000 -15.35%
2024 21.777.000 11.15%

SciDev Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.57
Net Income per Share
0.01
Price to Earning Ratio
51.94x
Price To Sales Ratio
1.04x
POCF Ratio
17.43
PFCF Ratio
25.58
Price to Book Ratio
2.25
EV to Sales
1
EV Over EBITDA
12.46
EV to Operating CashFlow
16.76
EV to FreeCashFlow
24.61
Earnings Yield
0.02
FreeCashFlow Yield
0.04
Market Cap
0,11 Bil.
Enterprise Value
0,11 Bil.
Graham Number
0.26
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0.01
Income Quality
2.98
ROE
0.04
Return On Assets
0.03
Return On Capital Employed
0.09
Net Income per EBT
0.53
EBT Per Ebit
0.89
Ebit per Revenue
0.04
Effective Tax Rate
0.47

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.11
Operating Profit Margin
0.04
Pretax Profit Margin
0.04
Net Profit Margin
0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.03
Free CashFlow per Share
0.02
Capex to Operating CashFlow
0.32
Capex to Revenue
0.02
Capex to Depreciation
0.5
Return on Invested Capital
0.05
Return on Tangible Assets
0.04
Days Sales Outstanding
41.11
Days Payables Outstanding
56.19
Days of Inventory on Hand
28.15
Receivables Turnover
8.88
Payables Turnover
6.5
Inventory Turnover
12.97
Capex per Share
0.01

Balance Sheet

Cash per Share
0,05
Book Value per Share
0,26
Tangible Book Value per Share
0.15
Shareholders Equity per Share
0.26
Interest Debt per Share
0.02
Debt to Equity
0.07
Debt to Assets
0.05
Net Debt to EBITDA
-0.49
Current Ratio
1.49
Tangible Asset Value
0,03 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
42249000
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.29
Average Receivables
0,01 Bil.
Average Payables
0,02 Bil.
Average Inventory
7802500
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

SciDev Limited Dividends
Year Dividends Growth

SciDev Limited Profile

About SciDev Limited

SciDev Limited engages in supply of process control, professional services, equipment design and construction, and chemistry in Australia and the United States. The company offers coagulants and flocculants in powder and liquid form under the MaxiFlox and MaxiDry name; engineering and process control; chemistry products for applications, including thickening, filtration, centrifuging, friction reduction, shale inhibition, rheology control, and carrier fluids; chemical batching, storage, and dosage systems; engineering solutions and technologies under the TrueMud and OptiFlox name; friction reducers under the DrySlik, WetSlik, and CarrySlik names; and dynamic shears. It serves water and wastewater treatment, mining and minerals processing, oil and gas, construction, food processing, dairy, power generation, personal products and cosmetics manufacturing, paper and cardboard manufacturing, and paint manufacturing industries. The company was formerly known as Intec Limited and changed its name to SciDev Limited in March 2017. SciDev Limited was incorporated in 1973 and is headquartered in Kings Park, Australia.

CEO
Mr. Sean Halpin
Employee
22
Address
Unit 1
Kings Park, 2148

SciDev Limited Executives & BODs

SciDev Limited Executives & BODs
# Name Age
1 Mr. Sean Halpin
Chief Executive Officer
70
2 Mr. Heath L. Roberts Dip Law (SAB)
Company Secretary & General Counsel
70
3 Ms. Sarah Stewart
Head of Client Experience & Marketing
70
4 Ms. Anna Hooper
Chief Financial Officer
70
5 Ollie Kelly
Head of People & Culture
70
6 Mr. Chris Dartez
Head of the Energy Services
70
7 Mr. Jamiel Muhor
Head of Mining & Construction
70
8 Mr. Mick Cox
Business Unit Head of Water Technologies APAC
70

SciDev Limited Competitors